FTO/m6A/GPNMB axis: a novel promising target for hepatocellular carcinoma (HCC) treatment?

被引:1
|
作者
Heinrich, Bernd [1 ]
Javier Cubero, Francisco [2 ,3 ]
机构
[1] Hannover Med Sch, Gastroenterol Hepatol Infect Dis & Endocrinol, Hannover, Germany
[2] Univ Complutense Madrid, Fac Med, Immunol Ophthalmol & ENT, Madrid, Spain
[3] Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain
关键词
HEPATOCELLULAR CARCINOMA; IMMUNE RESPONSE;
D O I
10.1136/gutjnl-2024-332934
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Insight into the regulatory mechanism of m6A modification: From MAFLD to hepatocellular carcinoma
    Zha, Xuan
    Gao, Zewei
    Li, Min
    Xia, Xueli
    Mao, Zhenwei
    Wang, Shengjun
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 177
  • [32] m6A epitranscriptomic modification in hepatocellular carcinoma: implications for the tumor microenvironment and immunotherapy
    Liu, Fen
    Liu, Qingbin
    Li, Xianying
    Wang, Yufei
    Cao, Ruoyu
    Zhang, Shiyu
    Jiang, Shulong
    Wu, Jianlin
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [33] Roles of M6A Regulators in Hepatocellular Carcinoma: Promotion or Sup-pression
    Chen, Jiamao
    Zhang, Qian
    Liu, Ting
    Tang, Hua
    CURRENT GENE THERAPY, 2022, 22 (01) : 40 - 50
  • [34] Recruitment of the m6A/m6Am demethylase FTO to target RNAs by the telomeric zinc finger protein ZBTB48
    Nabeel-Shah, Syed
    Pu, Shuye
    Burke, Giovanni L.
    Ahmed, Nujhat
    Braunschweig, Ulrich
    Farhangmehr, Shaghayegh
    Lee, Hyunmin
    Wu, Mingkun
    Ni, Zuyao
    Tang, Hua
    Zhong, Guoqing
    Marcon, Edyta
    Zhang, Zhaolei
    Blencowe, Benjamin J.
    Greenblatt, Jack F.
    GENOME BIOLOGY, 2024, 25 (01):
  • [35] m6A RNA methylation: a pivotal regulator of tumor immunity and a promising target for cancer immunotherapy
    Chen, Xi
    Yuan, Yixiao
    Zhou, Fan
    Li, Lihua
    Pu, Jun
    Jiang, Xiulin
    JOURNAL OF TRANSLATIONAL MEDICINE, 2025, 23 (01)
  • [36] N6-adenosine methylation (m6A): a promising new molecular target in hypertension and cardiovascular diseases
    Paramasivam, Arumugam
    Vijayashree Priyadharsini, Jayaseelan
    Raghunandhakumar, Subramanian
    HYPERTENSION RESEARCH, 2020, 43 (02) : 153 - 154
  • [37] N6-adenosine methylation (m6A): a promising new molecular target in hypertension and cardiovascular diseases
    Arumugam Paramasivam
    Jayaseelan Vijayashree Priyadharsini
    Subramanian Raghunandhakumar
    Hypertension Research, 2020, 43 : 153 - 154
  • [38] Novel positioning from obesity to cancer: FTO, an m6A RNA demethylase, regulates tumour progression
    JiaLing Chen
    Bin Du
    Journal of Cancer Research and Clinical Oncology, 2019, 145 : 19 - 29
  • [39] Novel positioning from obesity to cancer: FTO, an m6A RNA demethylase, regulates tumour progression
    Chen, JiaLing
    Du, Bin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (01) : 19 - 29
  • [40] R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m6A/PFKP/LDHB axis
    Qing, Ying
    Dong, Lei
    Gao, Lei
    Li, Chenying
    Li, Yangchan
    Han, Li
    Prince, Emily
    Tan, Brandon
    Deng, Xiaolan
    Wetzel, Collin
    Shen, Chao
    Gao, Min
    Chen, Zhenhua
    Li, Wei
    Zhang, Bin
    Braas, Daniel
    ten Hoeve, Johanna
    Sanchez, Gerardo Javier
    Chen, Huiying
    Chan, Lai N.
    Chen, Chun-Wei
    Ann, David
    Jiang, Lei
    Muschen, Markus
    Marcucci, Guido
    Plas, David R.
    Li, Zejuan
    Su, Rui
    Chen, Jianjun
    MOLECULAR CELL, 2021, 81 (05) : 922 - +